Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sawa Ito
Affiliation
University of Pittsburgh
ORCID
Career Start Year
2013
Papers
51
H Index
20
Expertise
CM4AI Collaborator
Jake Y. Chen (CM4AI)
PMID
Paper Title
Journal Title
Published Year
35411048
Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells.
Nat Commun
2022
35411048
Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells.
Nat Commun
2022
31439674
Predisposition to hematologic malignancies in patients with xeroderma pigmentosum.
Haematologica
2020
32105293
Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.
JAMA Oncol
2020
34595451
Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors.
Clin Hematol Int
2020
34589945
Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation.
JTO Clin Res Rep
2020
31439674
Predisposition to hematologic malignancies in patients with xeroderma pigmentosum.
Haematologica
2020
34589945
Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation.
JTO Clin Res Rep
2020
34595451
Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors.
Clin Hematol Int
2020
32105293
Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.
JAMA Oncol
2020
30342913
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
2019
30104719
Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study.
Bone Marrow Transplant
2019
30342913
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
2019
30292745
Over-expression of PD-1 Does Not Predict Leukemic Relapse after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
2019
29958797
Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes.
Cytokine
2019
31501157
Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.
Blood Adv
2019
31406955
Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology.
JCO Precis Oncol
2019
30104719
Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study.
Bone Marrow Transplant
2019
29958797
Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes.
Cytokine
2019
31501157
Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.
Blood Adv
2019
31406955
Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology.
JCO Precis Oncol
2019
30292745
Over-expression of PD-1 Does Not Predict Leukemic Relapse after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
2019
29197677
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34<sup>+</sup> Selection versus CD3<sup>+</sup>/19<sup>+</sup> Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
2018
29035398
Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
Bone Marrow Transplant
2018
29197677
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34<sup>+</sup> Selection versus CD3<sup>+</sup>/19<sup>+</sup> Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
2018
29035398
Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
Bone Marrow Transplant
2018
28653329
Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia.
Transfusion
2017
28462085
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia.
Leuk Res Rep
2017
28794968
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infection.
Leuk Res Rep
2017
28653329
Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia.
Transfusion
2017
28395942
Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Cytotherapy
2017
28287645
High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.
Bone Marrow Transplant
2017
28462085
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia.
Leuk Res Rep
2017
28395942
Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Cytotherapy
2017
28287645
High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.
Bone Marrow Transplant
2017
28794968
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infection.
Leuk Res Rep
2017
26190358
CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.
Support Care Cancer
2016
27433923
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
Br J Haematol
2016
27042843
Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors.
Bone Marrow Transplant
2016
26765645
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.
Lancet Haematol
2016
26764034
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.
J Immunol
2016
26190358
CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.
Support Care Cancer
2016
27643867
Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.
Bone Marrow Transplant
2016
27595279
Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.
Bone Marrow Transplant
2016
27643867
Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.
Bone Marrow Transplant
2016
27595279
Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.
Bone Marrow Transplant
2016
27433923
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
Br J Haematol
2016
27042843
Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors.
Bone Marrow Transplant
2016
26765645
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.
Lancet Haematol
2016
26764034
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.
J Immunol
2016
1 - 50 of 102
Column Actions
Search
Recommended Authors
Leo Ruhnke
University Hospital Dresden
Career Start Year
2018
Number of shared co-authors
0
Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Career Start Year
2018
Number of shared co-authors
1
Molly Maloy
Memorial Sloan Kettering Cancer Center
Career Start Year
2013
Number of shared co-authors
0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year
2008
Number of shared co-authors
1
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year
2008
Number of shared co-authors
0
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year
2007
Number of shared co-authors
0
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
1
Geoffrey D E Cuvelier
University of Manitoba
Career Start Year
2005
Number of shared co-authors
3
Laura F Newell
Oregon Health and Science University
Career Start Year
2003
Number of shared co-authors
0
Eneida R Nemecek
Oregon Health Sciences University
Career Start Year
2002
Number of shared co-authors
3
Ivan Pasic
Princess Margaret Cancer Centre
Career Start Year
2001
Number of shared co-authors
0
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year
1997
Number of shared co-authors
1
Leslie Lehmann
Dana Farber Cancer Institute/Boston Children's Hospital
Career Start Year
1996
Number of shared co-authors
1
David A Rizzieri
Duke University Medical Center
Career Start Year
1995
Number of shared co-authors
4
Thoralf Lange
Hospital Weissenfels
Career Start Year
1994
Number of shared co-authors
0
Gabrielle Meyers
Oregon Health and Science University
Career Start Year
1994
Number of shared co-authors
1
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year
1992
Number of shared co-authors
0
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year
1990
Number of shared co-authors
1
Peter Westervelt
Washington University School of Medicine
Career Start Year
1990
Number of shared co-authors
2
Koen van Besien
University Hospitals of Cleveland
Career Start Year
1988
Number of shared co-authors
2
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year
1987
Number of shared co-authors
3
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year
1987
Number of shared co-authors
1
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year
1986
Number of shared co-authors
7
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year
1986
Number of shared co-authors
4
Denis-Claude Roy
Universite de Montreal
Career Start Year
1985
Number of shared co-authors
0
Richard T Maziarz
Oregon Health & Science University
Career Start Year
1983
Number of shared co-authors
4
Dietger Niederwieser
University of Leipzig
Career Start Year
1982
Number of shared co-authors
0
Kenneth B Miller
Tufts Medical Center
Career Start Year
1981
Number of shared co-authors
0
John F DiPersio
Washington University School of Medicine
Career Start Year
1978
Number of shared co-authors
4
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Career Start Year
1976
Number of shared co-authors
8
row(s) 1 - 30 of 30
Collaborators
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Co-authored papers
9
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers
6
Neal S Young
National Heart Lung and Blood Institute Division of Intramural Research
Co-authored papers
6
Xingmin Feng
and Blood Institute, National Institutes of Health
Co-authored papers
5
Ronald E Gress
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Zhijie Wu
and Blood Institute, National Institutes of Health
Co-authored papers
2
Jinguo Chen
Center for Human Immunology
Co-authored papers
2
Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers
2
Aarthi Shenoy
MedStar Washington Hospital Center
Co-authored papers
2
Marcus Y Chen
and Blood Institute, National Institutes of Health
Co-authored papers
2
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
2
Prapti Patel
The University of Texas Southwestern Medical Center
Co-authored papers
1
Frances T Hakim
National Cancer Institute
Co-authored papers
1
Harvey G Klein
Clinical Center, National Institutes of Health
Co-authored papers
1
John J O'Shea
National Institute of Arthritis, National Institutes of Health
Co-authored papers
1
Zongliang Yue
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers
1
Jared E Knickelbein
University of Pittsburgh
Co-authored papers
1
Sung Won Choi
University of Michigan ann arbor
Co-authored papers
1
Robert B Nussenblatt
National Eye Institute
Co-authored papers
1
Jake Y Chen
Co-authored papers
1
Jeremy J Rose
National Cancer Institute
Co-authored papers
1
Ligia A Pinto
Frederick National Laboratory for Cancer Research
Co-authored papers
1
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers
1
Lauren A Taylor
Indiana University School of Medicine
Co-authored papers
1
Jake Y. Chen (CM4AI)
University of Alabama at Birmingham
Co-authored papers
1
Kristin Baird
National Cancer Institute, National Institutes of Health
Co-authored papers
1
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Co-authored papers
1
Yimou Cao
Indiana University School of Informatics and Computing
Co-authored papers
1
Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers
1
1 - 30